Jul 14 2010
FDA approves first implantable telescope for end-stage macular degeneration
The U.S. Food and Drug Administration recently announced that it has approved new technology that could help improve vision to people age 75 or older with end-stage, age-related macular degeneration.
The Implantable Miniature Telescope (IMT) just approved by the FDA is a first-of-its kind device, according to the manufacturer, VisionCare Ophthalmic Technologies.
To learn more, see the company’s on-line patient information booklet at www.centrasight.com
Editor’s Notes: For dietary and nutritional recommendations for those with AMD or those at risk, Click Here
Comments Off
